Company Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron to Report Third Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2014

[PR Newswire] – TARRYTOWN, N.Y., Oct. 15, 2014 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its third quarter 2014 financial and operating results on Tuesday, November . . . → Read More: Company Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron to Report Third Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2014 Similar Articles: Stock Update (NASDAQ:REGN): EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO) Market Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Company Update (NASDAQ:REGN): Regeneron Announces Upcoming 2014 Investor Conference Presentations